Invesco Ltd. - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 270 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$6,260,295
-13.3%
163,925
-6.7%
0.00%0.0%
Q2 2023$7,223,579
-27.3%
175,628
+1.4%
0.00%
-33.3%
Q1 2023$9,941,633
-17.0%
173,169
-19.0%
0.00%
-25.0%
Q4 2022$11,979,804
+67.2%
213,658
+26.4%
0.00%
+100.0%
Q3 2022$7,163,000
-27.0%
169,088
-6.9%
0.00%
-33.3%
Q2 2022$9,811,000
-5.1%
181,615
+12.8%
0.00%0.0%
Q1 2022$10,343,000
-0.6%
160,948
+3.6%
0.00%0.0%
Q4 2021$10,405,000
-5.3%
155,325
-3.2%
0.00%0.0%
Q3 2021$10,985,000
+5.3%
160,415
+4.9%
0.00%0.0%
Q2 2021$10,435,000
-62.8%
152,922
-62.3%
0.00%
-57.1%
Q1 2021$28,057,000
-14.6%
406,095
-19.8%
0.01%
-30.0%
Q4 2020$32,864,000
+18.3%
506,217
-14.0%
0.01%
+11.1%
Q3 2020$27,782,000
-7.4%
588,353
-7.9%
0.01%
-18.2%
Q2 2020$30,004,000
+406.8%
638,512
+381.8%
0.01%
+450.0%
Q1 2020$5,920,000
+7.1%
132,526
+39.8%
0.00%0.0%
Q4 2019$5,525,000
-92.2%
94,795
-92.0%
0.00%
-89.5%
Q3 2019$71,174,000
+4.1%
1,184,853
-3.2%
0.02%
+5.6%
Q2 2019$68,394,000
+1.8%
1,224,594
+1.5%
0.02%
-21.7%
Q1 2019$67,203,000
+23.3%
1,206,089
-0.2%
0.02%
+9.5%
Q4 2018$54,514,000
-27.6%
1,208,739
+5.8%
0.02%
-12.5%
Q3 2018$75,272,000
+3.2%
1,142,734
+0.9%
0.02%0.0%
Q2 2018$72,942,000
-5.7%
1,132,461
-19.0%
0.02%
-17.2%
Q1 2018$77,325,000
+9.7%
1,397,276
-5.1%
0.03%
+16.0%
Q4 2017$70,495,000
-11.4%
1,472,933
-6.5%
0.02%
-13.8%
Q3 2017$79,521,000
-9.0%
1,575,282
-1.8%
0.03%
+7.4%
Q2 2017$87,421,000
+29.8%
1,603,762
+0.3%
0.03%
+22.7%
Q1 2017$67,358,000
-1.9%
1,598,825
+99.8%
0.02%
-4.3%
Q4 2016$68,642,000
+353.4%
800,117
+336.3%
0.02%
+360.0%
Q3 2016$15,140,000
+17.5%
183,404
+13.5%
0.01%0.0%
Q2 2016$12,887,000
+85.5%
161,532
+56.7%
0.01%
+66.7%
Q1 2016$6,946,000
-8.2%
103,111
-7.6%
0.00%0.0%
Q4 2015$7,564,000
+21.9%
111,592
+7.1%
0.00%0.0%
Q3 2015$6,205,000
+0.0%
104,200
+13.2%
0.00%
+50.0%
Q2 2015$6,202,000
+21.2%
92,060
+10.9%
0.00%0.0%
Q1 2015$5,119,000
+21.2%
83,023
+6.6%
0.00%0.0%
Q4 2014$4,225,000
-89.3%
77,911
-90.2%
0.00%
-87.5%
Q3 2014$39,623,000
+5.7%
798,213
+0.2%
0.02%
+6.7%
Q2 2014$37,472,000
+1.4%
796,249
-0.9%
0.02%0.0%
Q1 2014$36,942,000
-2.4%
803,259
+1.2%
0.02%0.0%
Q4 2013$37,850,000
+20.2%
793,343
+1.4%
0.02%
+7.1%
Q3 2013$31,478,000
+41.0%
782,064
+28.3%
0.01%
+40.0%
Q2 2013$22,330,000609,6080.01%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q1 2023
NameSharesValueWeighting ↓
Champlain Investment Partners, LLC 5,473,820$305,001,0002.66%
FALCON POINT CAPITAL, LLC 80,729$4,498,0002.45%
Tributary Capital Management, LLC 508,838$28,352,0002.06%
Broadfin Capital, LLC 141,572$7,888,0001.63%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 182,585$10,174,0001.57%
Sapience Investments, LLC 132,810$7,400,0000.98%
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. 1,110,177$61,860,0000.83%
Bellevue Group AG 222,350$12,389,0000.68%
Capital International Sarl 74,325$4,141,0000.52%
Hood River Capital Management LLC 180,772$10,073,0000.51%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders